Market Cap
$3.42T
+2.4% today
Sector & Industry
Healthcare
Biotechnology
SEC Filings
274
Total filings on record
Last Filing
Jan 26, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| 13F | Jan 26, 2026 | Jan 26, 2026 | Institutional Investment Manager Holdings Report | 0006136053-26-453412 | |
| 10-Q | Dec 27, 2025 | Dec 27, 2025 | Quarterly Report for period ended March 2025 | 0006136053-26-386910 | |
| DEF 14A | Dec 4, 2025 | Dec 4, 2025 | Definitive Proxy Statement for Annual Meeting | 0006136053-26-300147 | |
| 10-K | Nov 5, 2025 | Nov 5, 2025 | Annual Report for fiscal year ended June 2025 | 0006136053-26-545404 | |
| 13F | Oct 10, 2025 | Oct 10, 2025 | Institutional Investment Manager Holdings Report | 0006136053-26-728302 | |
| 10-K | Sep 8, 2025 | Sep 8, 2025 | Annual Report for fiscal year ended June 2025 | 0006136053-26-743133 | |
| 8-K | Aug 15, 2025 | Aug 15, 2025 | Current Report - Material Event Disclosure | 0006136053-26-852104 | |
| DEF 14A | Jul 8, 2025 | Jul 8, 2025 | Definitive Proxy Statement for Annual Meeting | 0006136053-26-694081 | |
| 8-K | Jun 16, 2025 | Jun 16, 2025 | Current Report - Material Event Disclosure | 0006136053-26-916356 | |
| Form 4 | May 25, 2025 | May 25, 2025 | Statement of Changes - Jennifer Miller | 0006136053-26-520879 | |
| 10-K | Apr 18, 2025 | Apr 18, 2025 | Annual Report for fiscal year ended June 2025 | 0006136053-25-770731 | |
| 13F | Mar 25, 2025 | Mar 25, 2025 | Institutional Investment Manager Holdings Report | 0006136053-25-791978 | |
| Form 4 | Feb 21, 2025 | Feb 21, 2025 | Statement of Changes - James Johnson | 0006136053-25-972920 | |
| Form 4 | Jan 28, 2025 | Jan 28, 2025 | Statement of Changes - Sarah Brown | 0006136053-25-363094 | |
| 8-K | Dec 27, 2024 | Dec 27, 2024 | Current Report - Material Event Disclosure | 0006136053-25-608951 |